Cochlear Ltd. | Ownership
Companies that own Cochlear Ltd.
Baillie Gifford & Co.
4,532,973
7.86%
-319,952
0.44%
07/31/2018
Hyperion Asset Management Ltd.
2,741,200
4.75%
-616,801
13.47%
02/12/2018
BlackRock Fund Advisors
1,914,672
3.32%
-274,006
0.02%
05/25/2018
The Vanguard Group, Inc.
1,501,220
2.6%
8,611
0.01%
07/31/2018
AllianceBernstein LP
761,083
1.32%
174,808
0.07%
07/31/2018
BlackRock Investment Management (Australia) Ltd.
664,060
1.14%
57,716
0.49%
05/25/2018
Norges Bank Investment Management
663,356
1.14%
132,991
0.01%
12/31/2017
Walter Scott & Partners Ltd.
504,600
0.88%
0
0.22%
06/30/2018
Vanguard Investments Australia Ltd.
415,293
0.72%
6,298
0.13%
07/31/2018
T. Rowe Price International Ltd.
348,959
0.61%
62
0.1%
06/30/2018
| Address |
1 University Avenue
Sydney New South Wales (NSW) 2109
Australia
|
|
Employees
|
- |
| Website |
http://www.cochlear.com |
| Updated |
07/08/2019 |
| Cochlear Ltd. engages in the provision of implantable hearing solutions. It operates through following segments: Americas; Europe, Middle East & Africa; and Asia Pacific. Its products include cochlear, bone conduction and acoustic implants. |
